[
  {
    "ts": "2026-01-05T14:10:52+00:00",
    "headline": "Will Thermo Fisher’s Pharma Demand Outlook and Clario Deal Reframe Its Investment Story (TMO)?",
    "summary": "In recent days, Thermo Fisher Scientific has moved closer to its upcoming January 29, 2026 fourth-quarter and full-year 2025 earnings release, with investors closely tracking management’s pending updates on pharma and biotech demand, margins, and the progress of its planned Clario acquisition. This focus on commentary about high-end instrument demand, customer budgets, and margin trends highlights how much weight investors place on Thermo Fisher’s outlook and operating efficiency. Next,...",
    "url": "https://finance.yahoo.com/news/thermo-fisher-pharma-demand-outlook-141052165.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "1e0fdeca-8627-3164-b32c-89474a12e317",
      "content": {
        "id": "1e0fdeca-8627-3164-b32c-89474a12e317",
        "contentType": "STORY",
        "title": "Will Thermo Fisher’s Pharma Demand Outlook and Clario Deal Reframe Its Investment Story (TMO)?",
        "description": "",
        "summary": "In recent days, Thermo Fisher Scientific has moved closer to its upcoming January 29, 2026 fourth-quarter and full-year 2025 earnings release, with investors closely tracking management’s pending updates on pharma and biotech demand, margins, and the progress of its planned Clario acquisition. This focus on commentary about high-end instrument demand, customer budgets, and margin trends highlights how much weight investors place on Thermo Fisher’s outlook and operating efficiency. Next,...",
        "pubDate": "2026-01-05T14:10:52Z",
        "displayTime": "2026-01-05T14:10:52Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/bbf788be9fece7d0a8c4e3c9f7496edb",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/nAcMRxWCuAxw3qhVHcWZng--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/bbf788be9fece7d0a8c4e3c9f7496edb.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/.zKjtqc4mXGardOqBxRIpg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/bbf788be9fece7d0a8c4e3c9f7496edb.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/thermo-fisher-pharma-demand-outlook-141052165.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/thermo-fisher-pharma-demand-outlook-141052165.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "TMO"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]